NAT1,NOS3, and TYMS genotypes and the risk of conotruncal cardiac defects

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue 1, 2011, Pages 61-65

  Lupo, Philip J ^a   Mitchell, Laura E ^a   Goldmuntz, Elizabeth ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Conotruncal cardiac defects; Folate; NAT1 gene; NOS3 gene; TYMS gene

Indexed keywords

FOLIC ACID; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

AORTA ARCH ANOMALY; AORTA ARCH INTERRUPTION; ARTICLE; CONGENITAL HEART MALFORMATION; FALLOT TETRALOGY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GREAT VESSELS TRANSPOSITION; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; NAT1 GENE; NOS3 GENE; NUTRITIONAL STATUS; PRIORITY JOURNAL; TYMS GENE;

ADULT; ARYLAMINE N-ACETYLTRANSFERASE; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART DEFECTS, CONGENITAL; HUMANS; ISOENZYMES; MALE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THYMIDYLATE SYNTHASE;

EID: 78751485169     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20745     Document Type: Article

References (30)

1. Botto LD, Lin AE, Riehle-Colarusso T, et al. 2007. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 79(10): 714-727.
2. Brown KS, Cook M, Hoess K, et al. 2004. Evidence that the risk of spina bifida is influenced by genetic variation at the NOS3 locus. Birth Defects Res A Clin Mol Teratol 70(3): 101-106.
3. Brown KS, Kluijtmans LA, Young IS, et al. 2003. Genetic evidence that nitric oxide modulates homocysteine: the NOS3 894TT genotype is a risk factor for hyperhomocystenemia. Arterioscler Thromb Vasc Biol 23(6): 1014-1020.
4. Goldmuntz E, Woyciechowski S, Renstrom D, et al. 2008. Variants of folate metabolism genes and the risk of conotruncal cardiac defects. Circ Cardiovasc Genet 1(2): 126-132.
5. Hobbs CA, James SJ, Parsian A, et al. 2006. Congenital heart defects and genetic variants in the methylenetetrahydroflate reductase gene. J Med Genet 43(2): 162-166.
6. Jenkins KJ, Correa A, Feinstein JA, et al. 2007. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115(23): 2995-3014.
7. Jensen LE, Hoess K, Mitchell LE, et al. 2006. Loss of function polymorphisms in NAT1 protect against spina bifida. Hum Genet 120(1): 52-57.
8. Kealey C, Brown KS, Woodside JV, et al. 2005. A common insertion/deletion polymorphism of the thymidylate synthase (TYMS) gene is a determinant of red blood cell folate and homocysteine concentrations. Hum Genet 116(5): 347-353.
9. Kistner EO, Weinberg CR. 2004. Method for using complete and incomplete trios to identify genes related to a quantitative trait. Genet Epidemiol 27(1): 33-42.
10. Lammer EJ, Shaw GM, Iovannisci DM, et al. 2004. Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and risk for orofacial clefts. Birth Defects Res A Clin Mol Teratol 70(11): 846-852.
11. Liu J, Schmitz JC, Lin X, et al. 2002. Thymidylate synthase as a translational regulator of cellular gene expression. Biochim Biophys Acta 1587(2-3): 174-182.
12. Lupo PJ, Goldmuntz E, Mitchell LE. 2010. Gene-gene interactions in the folate metabolic pathway and the risk of conotruncal heart defects. J Biomed Biotechnol 2010: 630940.
13. Mandola MV, Stoehlmacher J, Zhang W, et al. 2004. A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels. Pharmacogenetics 14(5): 319-327.
14. McElhinney DB, Clark BJ3rd, Weinberg PM, et al. 2001. Association of chromosome 22q11 deletion with isolated anomalies of aortic arch laterality and branching. J Am Coll Cardiol 37(8): 2114-2119.
15. McElhinney DB, Driscoll DA, Levin ER, et al. 2003. Chromosome 22q11 deletion in patients with ventricular septal defect: frequency and associated cardiovascular anomalies. Pediatrics 112(6 pt 1): e472.
16. Minchin RF. 1995. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochem J 307(pt 1): 1-3.
17. Mitchell LE, Long J, Garbarini J, et al. 2010. Variants of folate metabolism genes and risk of left-sided cardiac defects. Birth Defects Res A Clin Mol Teratol 88(1): 48-53.
18. Pei L, Zhu H, Zhu J, et al. 2006. Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial defects and congenital heart defects in China. Ann Epidemiol 16(5): 352-356.
19. Rosenquist TH, Ratashak SA, Selhub J. 1996. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci U S A 93(26): 15227-15232.
20. Shaw GM, Iovannisci DM, Yang W, et al. 2005. Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Med Genet A 138(1): 21-26.
21. Shaw GM, Lu W, Zhu H, et al. 2009. 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. BMC Med Genet 10: 49.
22. Stanley LA, Copp AJ, Pope J, et al. 1998. Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain. Teratology 58(5): 174-182.
23. Trinh BN, Ong CN, Coetzee GA, et al. 2002. Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet 111(3): 299-302.
24. Ulrich CM, Bigler J, Bostick R, et al. 2002. Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res 62(12): 3361-3364.
25. van Beynum IM, Mooij C, Kapusta L, et al. 2008. Common 894G>T single nucleotide polymorphism in the gene coding for endothelial nitric oxide synthase (eNOS) and risk of congenital heart defects. Clin Chem Lab Med 46(10): 1369-1375.
26. Vermunt JK. 1997. LEM: a general program for the analysis of categorical data. Tilberg University.
27. Volcik KA, Shaw GM, Zhu H, et al. 2003. Associations between polymorphisms within the thymidylate synthase gene and spina bifida. Birth Defects Res A Clin Mol Teratol 67(11): 924-928.
28. Wang XL, Sim AS, Wang MX, et al. 2000. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett 471(1): 45-50.
29. Weinberg CR. 1999. Allowing for missing parents in genetic studies of case-parent triads. Am J Hum Genet 64(4): 1186-1193.
30. Weinberg CR, Wilcox AJ, Lie RT. 1998. A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet 62(4): 969-978.